Approval for the AIA-PACK PA.  The device is designed for in vitro diagnostic use only for the quantitative measurement of Prostate Specific Antigen (PSA) in human serum on TOSOH AIA System analyzers.  This device is indicated for the measurement of serum PSA in conjunction with Digital Rectal Examination (DRE) as an aid in the detection of prostate cancer (CaP) in men fifty years of age and older. Prostate biopsy is required for the diagnosis of cancer.  The device is further indicated for the serial measurement of PSA in human serum to be used as an aid in the management of patients with prostatic cancer.